Department of Endocrine Surgery, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University.
Department of Nuclear Medicine, Bicetre Hospital, Assistance Publique Hôpitaux de Paris.
Clin Nucl Med. 2020 Jun;45(6):e281-e282. doi: 10.1097/RLU.0000000000003020.
Managing decisions of pancreatic neuroendocrine tumors (pNETs) can be challenging because of different clinical presentations and prognosis. A 31-year-old woman with multiple endocrine neoplasia type 1, including a suspicious pNET, was assessed with Ga-DOTATOC and F-FDG PET. A high Ga-DOTATOC uptake was visualized in the entire pNET, whereas a high F-FDG PET uptake was present only in the upper part of the tumor. After surgery, pathology confirmed the pNET with a double component: an upper grade 2 with a Ki67 of 11% with the high F-FDG PET uptake, and a lower grade 1 with a Ki67 of 2%. Combined Ga-DOTATOC/F-FDG PET predicts the grade in heterogeneous pNETs.
管理胰腺神经内分泌肿瘤(pNET)的决策可能具有挑战性,因为其临床表现和预后存在差异。一位患有多种内分泌肿瘤 1 型的 31 岁女性,包括疑似 pNET,接受了 Ga-DOTATOC 和 F-FDG PET 检查。整个 pNET 中可见 Ga-DOTATOC 摄取增加,而肿瘤的上半部分仅存在 F-FDG PET 摄取增加。手术后,病理证实 pNET 为双成分:Ki67 为 11%的高级 2 级,与高 F-FDG PET 摄取相关,Ki67 为 2%的低级 1 级。Ga-DOTATOC/F-FDG PET 联合检查可预测异质性 pNET 的分级。